Short Interest in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Expands By 75.6%

Sol-Gel Technologies Ltd. (NASDAQ:SLGLGet Free Report) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 88,700 shares, an increase of 75.6% from the November 30th total of 50,500 shares. Approximately 1.2% of the shares of the company are sold short. Based on an average trading volume of 387,900 shares, the days-to-cover ratio is presently 0.2 days.

Sol-Gel Technologies Stock Performance

Shares of SLGL stock traded down $0.10 during trading hours on Friday, reaching $1.12. The company had a trading volume of 397,713 shares, compared to its average volume of 222,272. The firm has a market cap of $31.20 million, a PE ratio of -3.29 and a beta of 1.62. The business has a fifty day moving average price of $0.60 and a 200-day moving average price of $0.65. Sol-Gel Technologies has a one year low of $0.33 and a one year high of $1.65.

Sol-Gel Technologies Company Profile

(Get Free Report)

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.

Featured Stories

Receive News & Ratings for Sol-Gel Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sol-Gel Technologies and related companies with MarketBeat.com's FREE daily email newsletter.